High quality raw material for IVD manufacturing industry

Recombinant nucleoprotein (N-term) antigen (NP-NTD) for SARS-CoV (2003)

RekomBiotech
SARS-CoV (2003)

NP (NTD) is the nucleoprotein N-terminal domain of the Coronavirus nucleocapsid (N). This recombinant antigen has been prepared by expressing aa 2 to 117 from de nucleoprotein of SARS-CoV. Coronavirus nucleocapsid (N) protein is a highly phosphorylated protein which not only is responsable for construction of the ribonucleoprotein complex by interacting with the viral genome and regulating the synthesis of viral RNA and protein, but also serves as a potent immunogen that induces humoral and cellular immunity. The nucleoprotein is one of the major antigens of the SARS-CoV and there are abundant antigenic sites predicted in this protein. Compared with other viral structural proteins, the low variation rate of the N protein with regards to its size suggests its importance to the survival of the virus.

This protein shows 87% identity with NP COVID-19.

View more information about Severe acute respiratory syndrome (SARS).

REFERENCES
COA RAG0082 new WB, DB, Indirect ELISA, positive control in direct ELISA, CLIA, lateral-flow
GENE
NP
DESCRIPTION
SARS-CoV nucleoprotein N-terminal domain
PURITY
>95% in a SDS-PAGE
SHIPPING AND STORAGE CONDITIONS
Proteins will be shipped with dry ice or lyophilized. Upon arrival (if liquid), or after reconstitution (if lyophilized), they should be stored at -20ºC to -80ºC. Avoid multiple freeze/thaw cycles
STABILITY
The protein will remain stable for four years if stored frozen
SPECIFICITY
Not tested. According to the literature, the protein is immunoreactive against seropositive individuals to Severe acute respiratory syndrome (SARS)
IVD
SARS-CoV serodiagnosis

FOR RESEARCH AND COMERCIAL USE IVD ONLY (*)

(*) Our antigens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our antigens, you can visit here.

RETURN TO HUMAN RECOMBINANT ANTIGENS